| abstract |
(A) glycopyrrolate for simultaneous, sequential or separate administration in the treatment of inflammatory or obstructive airway disease; And (B) a medicament comprising individually or together a compound of formula (1) in free form or in salt form or solvate form or a compound of formula (2) in free form or salt form or solvate form. Also described are pharmaceutical compositions containing (A) and (B). ≪ Formula 1 > (2) In the above formula, W, R x , R y , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and X have the meanings as described herein. |